LINC00692: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC00692

NCBI ID: G285326

LINC00692

Other Name(s): long intergenic non-protein coding RNA 692 | Long intergenic non-protein coding RNA 692

LINC00692: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC00692 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It has a unique structure that consists of a series of alternating intron-exon interactions, which gives it the name \"long intergenic non-protein-coding RNA.\" LINC00692 has been shown to play a critical role in various cellular processes, including cell growth, differentiation, and RNA homeostasis.

Drug Target Potential

The drug targeting potential of LINC00692 makes it an attractive candidate for further research. The unique structure of LINC00692, with its alternating intron-exon interactions, creates a potential binding site for small molecules. Additionally, the fact that LINC00692 is a non-protein-coding RNA also implies that it is not likely to have any natural binding partners, which could further enhance its drug targeting potential.

Biomarker Potential

LINC00692 has also been shown to have potential as a biomarker in various diseases. For example, LINC00692 has been shown to be downregulated in various cancer types, which suggests that it may have potential as a diagnostic or therapeutic target for cancer. Additionally, LINC00692 has been shown to be involved in the regulation of cellular processes that are important for human health, such as cell growth, differentiation, and inflammation. This suggests that it may have potential as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Methods

To further investigate the drug targeting potential of LINC00692, researchers have used a variety of techniques, including RNA sequencing and biochemical assays. These studies have shown that LINC00692 can be targeted by small molecules with high affinity and specificity. Additionally, researchers have used a variety of cellular models to demonstrate that LINC00692 can modulate cellular processes, including cell growth, apoptosis, and transcriptional regulation.

Conclusion

In conclusion, LINC00692 is a long non-coding RNA that has a unique structure and function. Its alternating intron-exon interactions and non-protein-coding nature make it an attractive candidate for drug targeting and biomarker development. Further research is needed to fully understand the drug targeting potential of LINC00692 and its potential as a biomarker for various diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 692

The "LINC00692 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00692 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets